Therapeutic Strategies to Activate p53

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The p53 protein is a critical tumor suppressor, often called the "guardian of the genome".
• Its function is compromised in nearly all human cancers through mutations (loss or gain of function) and inhibition by regulators like MDM2 and MDMX.
• Restoring p53 function presents a promising therapeutic avenue in cancer treatment.

Purpose of the Study:

• To review current therapeutic strategies targeting the p53 tumor suppressor protein.
• To highlight progress in developing treatments that address p53 dysfunction in cancer.

Main Methods:

• Comprehensive literature review of research on p53 therapeutic strategies.
• Analysis of mechanisms inhibiting p53 function in cancer.
• Evaluation of different approaches to target p53 and its regulators.

Main Results:

• Various therapeutic strategies are being developed to reactivate or restore p53 function.
• Approaches include targeting p53 mutations, inhibiting MDM2/MDMX, and other novel methods.
• Significant progress has been made in preclinical and clinical studies.

Conclusions:

• Targeting the compromised p53 pathway is a key strategy in cancer therapy.
• Continued research is essential to translate these findings into effective clinical treatments.
• Restoring the "guardian of the genome" function holds great potential for cancer patients.